NHS Health Data Use Case Study Library

Global Epidemiology of Hip Fractures - Amgen

By accessing patient data from 19 countries, Amgen looked into global trends in hip fracture incidence, treatment, and deaths in patients aged 50 and over.

Real World Evaluation of COVID-19 vaccines in England - AstraZeneca

AstraZeneca used a variety of patient databases, including GP records, vaccination history and hospital admissions reports, to evaluate real-world effectiveness and safety of one COVID-19 vaccine in England.

Cardiovascular risk profiles - Eli Lilly

This was a study looking at cardiovascular complications in patients with type 2 diabetes (T2D).

Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma - Ipsen

This study, funded by Ipsen, used patient data collected from hospital and prescription records, to analyse the type of treatment provided to patients with advanced kidney cancer in the United Kingdom and monitored their outcomes.

Incidence and characteristics of Invasive Fungal Infections in patients being treated with Systemic Anticancer Therapies in England - Pfizer

This study, carried out by Pfizer, used data from Hospital Episode Statistics data and the SACT registry dataset to explore the impact of invasive fungal infections (IFIs) in patients living with cancer.

A prospective observational post authorization safety sub-registry study to characterize the long-term safety profile of eliglustat in adult patients with Gaucher disease - Sanofi

This study, run by Sanofi, sought to gather data on patients being treated for Gaucher disease, to monitor the ongoing effectiveness of their licensed medicine.